| Advice Pool |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Drug Abuse > Dual Diagnosis, Drug Addiction, Alcoholism and Their Similarities |
|
Advice Pool - Dual Diagnosis, Drug Addiction, Alcoholism and Their Similarities
There are many similarities between drug addiction, alcoholism and a mental health disorder. While the combinati According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product on of a drug addiction or alcohol addiction and a mental health disorder is called a dual diagnosis, they should ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in all be treated simultaneously in a drug rehab, alcohol rehab or dual diagnosis treatment program. Below are the lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. listed similarities: 1. Drug addiction, alcoholism and mental health disorders are physiological diseases wit here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe strong genetic and hereditary components. 2. Drug addiction, alcoholism and mental health disorders are physic d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro l/mental/spiritual diseases. 3. Drug addiction, alcoholism and mental health disorders if left untreated are pr ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ogressive, chronic, incurable, and potentially fatal. 4. Denial of the disease of drug addiction, alcoholism an easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi mental health disorders and noncompliance with attempts at addiction treatment, drug rehab or dual diagnosis t nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically reatment are symptoms of the disorder. 5. Drug addiction, alcoholism and mental health disorders manifest loss and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ of control in behavior, thought, and emotions. 6. Drug addiction, alcoholism and mental health disorders effect ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi the whole family. 7. Growing powerlessness and unmanageability over drug addiction, alcoholism or mental illnes ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a s’s lead to feelings of guilt, shame, depression, and despair. 8. Drug addiction, alcoholism and mental health dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod isorders are diseases of vulnerability and isolation. 9. Both the primary symptoms of each disease AND loss of cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin control in behavior/thought/emotion are reversible with addiction treatment or dual diagnosis treatment. 10. Re tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen overy consists of: Stabilization of the acute disease Rehabilitation of body, mind, and spirit 11. The risk of t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel elapse in either disease is always high, and relapse in drug addiction or alcoholism will inevitably trigger a r ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust elapse in the mental health disorder. 12. The only hope for life-long recovery lies in working our Recovery Prog y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products am(s): ONE DAY AT A TIME If you are looking for an effective dual diagnosis treatment program, you can call the . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de dual diagnosis helpline at 1-800-511-92 elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Homeowner’s Insurance Advice: Taking Inventory of Your Home
|